Myoglobin and troponin I elevation predict 5-year mortality in patients with undifferentiated chest pain in the emergency department - 08/08/11
, Richard Nowak, MD b, Nabil Khoury, MD b, Glen Tokarski, MD b, David E. Lanfear, MD, MS c, Gordon Jacobsen, MD d, James McCord, MD cRiassunto |
Background |
The long-term prognostic significance of elevated cardiac markers in an undifferentiated patient population with chest pain is unknown.
Methods |
Serum troponin I (cTnI), creatine kinase-MB (CK-MB), and myoglobin were measured at presentation in 951 consecutive patients evaluated in the emergency department for possible acute coronary syndrome, and all-cause mortality was measured over 5 years.
Results |
Final diagnoses included myocardial infarction in 70 (7.4%), unstable angina in 78 (8.2%), stable angina in 26 (2.7%), heart failure in 135 (14.2%), syncope in 61 (6.4%), arrhythmia in 62 (6.5%), and noncardiac diagnoses in 519 (54.6%). Our study population had a mean (±SD) age of 63 (±16), 434 (46%) were male, 774 (81%) were African American, 408 (43%) had known coronary artery disease, 647 (68%) had hypertension, 244 (26%) had diabetes mellitus, and 237 (25%) had a serum creatinine ≥1.5 mg/dL. At 5 years, there were 349 (36.7%) deaths. In a multivariate model with adjustment for baseline covariates, an elevated cTnI ≥1.0 ng/mL (hazard ratio [HR] 1.7, 95% CI 1.3-2.3) and myoglobin ≥200 ng/mL (HR 1.6, 95% CI 1.2-2.1), but not CK-MB ≥9.0 ng/mL (HR 0.9, 95% CI 0.6-1.3), remained independent predictors of all-cause mortality. Patients with both elevated cTnI and myoglobin had a particularly high mortality rate.
Conclusion |
Among patients evaluated in the emergency department for possible acute coronary syndromes, myoglobin and cTnI at presentation are powerful, independent predictors of long-term (5-year) prognosis.
Il testo completo di questo articolo è disponibile in PDF.Mappa
Vol 156 - N° 5
P. 939-945 - Novembre 2008 Ritorno al numero
Articolo precedente
- Decreased activated protein C levels as a clinical predictor in patients with ST-elevation myocardial infarction
- Nobutaka Chiba, Ken Nagao, Takeo Mukoyama, Yoshiteru Tominaga, Katsuhisa Tanjoh
- Patterns of use and effectiveness of early invasive strategy in non–ST-segment elevation acute coronary syndromes: An assessment by propensity score
- Ignacio Ferreira-González, Gaietà Permanyer-Miralda, Magda Heras, José Cu?at, Emilia Civeira, Fernando Arós, Juan J. Rodríguez, Pedro L. Sánchez, Josep R. Marsal, Aida Ribera, Jaume Marrugat, Héctor Bueno, for the MASCARA study group j
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?